TUMOREND
DEAD

Serial Number

99076128

Owner

Tumorend, LLC

Filing Date

Mar 10, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TUMOREND Trademark

Serial Number: 99076128

TUMOREND is a trademark filed by Tumorend, LLC on March 10, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Tumorend, LLC (2 trademarks)

755 Delgado Dr.
Baton Rouge, LA 70808

Entity Type: 16

Trademark Details

Filing Date

March 10, 2025

Registration Date

Not Registered

Published for Opposition

September 9, 2025

Goods & Services

Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of tumors, burns, spinal cord injury; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 8, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 8, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 12, 2025 CNSA
ASSIGNED TO EXAMINER
Aug 11, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 10, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2025 NWOS
NEW APPLICATION ENTERED
Mar 10, 2025 NWAP